Evidence map›Paper›PMID 40304403›Full record

ArticleTherapeutic advances in respiratory disease

CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment.

Iris van Geer-Postmus, Marika T Leving, Yoran H Gerritsma, Esmé Baan, Lars Dijk, Evelien Harms, David Price, Gerian H Prins, Jennifer K Quint, Dermot Ryan and 4 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Iris van Geer-PostmusGeneral Practitioners Research Institute, Prof. ED Wiersmastraat 5, Groningen, 9713 GH, The Netherlands.ORCID 0009-0005-5394-216X
Marika T LevingGeneral Practitioners Research Institute, Groningen, The Netherlands.
Yoran H GerritsmaGeneral Practitioners Research Institute, Groningen, The Netherlands.
Esmé BaanDepartment of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.
Lars DijkGeneral Practitioners Research Institute, Groningen, The Netherlands.
Evelien HarmsGeneral Practitioners Research Institute, Groningen, The Netherlands.
David PriceOptimum Patient Care, Cambridge, United Kingdom of Great Britain and Northern Ireland.ORCID 0000-0002-9728-9992
Gerian H PrinsGeneral Practitioners Research Institute, Groningen, The Netherlands.
Jennifer K QuintSchool of Public Health, Imperial College London, London, UK.
Dermot RyanAllergy and Respiratory Group, Usher Institute, University of Edinburgh, Edinburgh, UK.
Philippe SaloméDutch COPD and Asthma GP Advisory Group (CAHAG), Utrecht, The Netherlands.
Björn StällbergDepartment of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden.
Nilouq StokerGeneral Practitioners Research Institute, Groningen, The Netherlands.
Janwillem H KocksGeneral Practitioners Research Institute, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevention of lung attacks (LAs)/exacerbation is an important treatment goal in both asthma and chronic obstructive pulmonary disease (COPD). However, LAs are often not registered as such in medical records.

objectivesDevelopment and evaluation of CodeX Asthma and COPD.

designAn electronic medical record-based algorithm to identify LAs in Dutch primary care patients with asthma or COPD was developed. The algorithms were evaluated in nine general practices in the Netherlands.

resultsA total of 479 LAs (in 1164 patients) were identified with CodeX Asthma in the past year, of which only 16% were registered. CodeX COPD identified 321 LAs (in 242 patients) in the past 3 years, of which two were registered.

conclusionCodeX algorithms are capable of identifying unrecorded LAs and high-risk/uncontrolled patients in an easy way. This offers primary care providers a simple solution to easily identify and closely manage high-risk patients with asthma or COPD by identifying LAs' frequency and potential under- or overtreatment.

Indexed as

AlgorithmsAsthmaElectronic Health RecordsPrimary Health CarePulmonary Disease, Chronic ObstructiveAdultAgedFemaleHumansMaleMiddle AgedNetherlandsPractice Guidelines as TopicRisk AssessmentRisk Factorsalgorithmasthmacardiopulmonary pathwayCOPDexacerbationslung attacksquality improvementtreatment optimalization

Identifiers

PMID40304403
PMCPMC12046172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.